SAGA Diagnostics

On-demand Satellite Symposium

Lao Saal, MD PhD - CEO, SAGA Diagnostics; Assoc. Professor, Lund University
"Ultrasensitive detection and monitoring of ctDNA using SAGAsafe® and SAGAsign® technologies"

Watch the symposium here

SAGA Diagnostics is a personalized cancer genomics and disease monitoring company that offers molecular genetic testing of tissue biopsies and non-invasive liquid biopsies such as blood samples. SAGAsafe® is part of a portfolio of ultrasensitive technologies, which also includes SAGAsign® for personalized monitoring of cancer burden using chromosomal rearrangements, as well as novel technologies in development. SAGA helps pharmaceutical companies, scientists, and healthcare providers to detect actionable mutations, stratify patient groups, and monitor treatment response more accurately and to an industry-leading lower limit of detection of 0.001%. Analysis of circulating tumor DNA using these proprietary technologies gives SAGA unique ultrasensitivity, and provides the basis for optimal decision-making.

Video

Resources

• SAGA advantages for cancer patients
• SAGA advantages for pharma companies
• SAGAsafe EGFR T790M CE-marked
• Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

Any questions? Contact:

Sven Langner
Sales Manager 
sven.langner@sagadiagnostics.com
 

Annina Hube
Director, Market Access
annina.hube@sagadiagnostics.com
 

Live chat

If you see a 'Let's chat' icon on the bottom right of the page, it means that a representative is online and ready to chat and answer your questions! Click on the icon to chat with them.

If you see a 'Send message' button it means nobody is online right now, but you can send an email instead.

Click here to get get in touch with SAGA Diagnostics